MedTrace Logo

Symptomatic Treatment of Acute Uncomplicated Diverticulitis

NCT02219698 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2015-07-31

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and efficacy of symptomatic treatment (i.e. without antimicrobial drugs) of acute uncomplicated diverticulitis.

Conditions

  • Diverticulitis

Interventions

DRUG

Ibuprofen

DRUG

Paracetamol

Sponsors & Collaborators

  • Vatsatautien tutkimussäätiö - foundation

    collaborator UNKNOWN

  • Mary and Georg Ehrnroot's foundation

    collaborator UNKNOWN

  • Finnish Surgical society

    collaborator UNKNOWN

  • Martti I. Turunen Foundation

    collaborator UNKNOWN

  • Governmental competitive funds (EVO)

    collaborator UNKNOWN

  • Helsinki University Central Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-07-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02219698 on ClinicalTrials.gov